Q1 2025 Management View The company announced a strategic restructuring to focus on its LineaRx subsidiary, exiting the DNA Tagging and Security Products and Services segment. This move is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback